Swiss biotech Noema raises $112m for Roche castoffs

Swiss biotech Noema raises $112m for Roche castoffs

Source: 
Pharmaphorum
snippet: 

Swiss biotech Noema has added another $112 million to its funding in an oversubscribed second round, as it takes neurological disorder drugs licensed in from Roche through clinical development.